Blend uniformity analysis: validation and in-process testing. Technical Report No. 25. PDA (Parenteral Drug...

Area of Science:

• Pharmaceutical Manufacturing
• Process Validation
• Drug Product Quality

Background:

• Blend uniformity validation is a critical challenge in oral solid dosage manufacturing.
• Regulatory scrutiny, influenced by the Wolin decision, has intensified focus on blend uniformity and sampling techniques.
• Current sampling technologies are often biased, failing to collect truly representative samples from large powder blends.

Purpose of the Study:

• To address the limitations of current sampling technology in blend uniformity validation.
• To provide a scientifically sound approach for blend uniformity analysis in pharmaceutical manufacturing.
• To guide the pharmaceutical industry in meeting high standards for blend uniformity.

Main Methods:

• Review of scientific literature on blend uniformity and sampling bias.
• Development of a method for determining appropriate sample sizes for powder blends.
• Establishment of a holistic approach for setting meaningful acceptance criteria.
• Discussion of suitable analytical techniques for blend uniformity assessment.

Main Results:

• Identified significant sampling bias in current technologies used for blend uniformity analysis.
• Proposed a method to calculate product-specific sample sizes.
• Outlined a comprehensive strategy for defining relevant acceptance criteria.
• Provided recommendations for investigating out-of-specification results.

Conclusions:

• Current sampling methods pose a significant challenge to accurate blend uniformity validation.
• A revised approach incorporating appropriate sample size, acceptance criteria, and analytical methods is necessary.
• This technical report offers practical guidance for improving blend uniformity analysis in pharmaceutical manufacturing.